Lymphokines

Contributors

Preface

Transfer Factor

I. Introduction

II. Progress toward Purification and Characterization of Transfer Factor

III. In Vitro Assays for Transfer Factor

IV. Recent Progress with Animal Models

V. On the Mechanism of Action

VI. Clinical Applications of Transfer Factor

VII. Summary and Conclusions

References

IgE-Binding Factors from Rat T Lymphocytes

I. Introduction

II. Role of IgE-Binding Factors in the Regulation of the IgE Response

II. Induction of IgE-Binding Factors with Biologic Activity

IV Conclusion

References

A Polyclonal B-Cell Activating Lymphokine and Its Natural Inhibitor: Possible Role in Antibody Formation and Autoimmune Diseases

I. Introduction

II. Hypothetical Models for Antibody Formation with a Role for a Polyclonal B-Cell Activator (PBA)

III. A Hypothetical Model for the Pathogenesis of Autoimmune Diseases without a Role for Antigens

IV. Methods for Detecting Polyclonal B-Cell Activators

V. Induction of a PBA in Cultures of Rabbit Lymphoid Cells

VI. The Molecular Nature of the PBA Produced in Lymphoid Cell Cultures

VII. The Cells Involved in the Production of PBA in Rabbit Lymphoid Cell Cultures

VIII. The Induction of PBA Associated with α-Macroglobulin (αM) in Vivo

IX. PBA in the Serum of Patients with Rheumatoid Arthritis and Other Autoimmune Diseases

X. The Molecular Nature of PBA Obtained from Patient Serum

XI. Low-Molecular-Weight PBA Inhibitor (LOMPIN) in the Serum of Patients with Rheumatoid Arthritis

XII. Discussion on the Mechanisms of Antibody Formation, Autoimmunity, and the Role of PBA

XIII. Summary and Conclusions

References

Lymphokines and Antigen-Specific T-Cell Products in Contact Sensitivity

I. Introduction

II. Ts-aff: The T Suppressor Cell Which Acts at the Afferent Stage of the Contact Sensitivity Reaction

III. T Suppressor Circuit Involving Ts-eff, TsF, and T Acceptor Cell and Nonspecific Inhibitor(s)

IV. T Suppressor Factor (TsF)

V. The T Acceptor Cell

VI. Nonspecific Inhibitor Released by the T Acceptor Cell

VII. The Macrophage as an Acceptor Cell

VIII. Function of the T Suppressor Circuits

IX. Summary

References

Studies on the Activation of Cytotoxicity and/or Suppressor Activity in Murine Macrophages by Lymphokines, Lipopolysaccharide, and Polyinosinic-Polycytidylic Acid

I. Introduction

II. Induction of Tumoricidal Macrophages in Vitro

III. Induction of Suppressor MΦ in Vitro

IV. Summary and Concluding Remarks

References

The Role of Clotting Processes in the Action of Lymphokines on Macrophages

I. Introduction

II. Fibrin Deposition in Delayed-type Hypersensitivity Reactions

III. Fibrin Deposition on Macrophage Populations

IV. Initiation of Coagulation by Lymphokines

V. Macrophage Procoagulant Activity (MPCA)

VI. MPCA as a Correlate of Cell-Mediated Immunity

VII. Macrophage Tumor Cell Lines as Indicator Cells of MPCA

VIII. Identification of the Procoagulant Activity

IX. Relationship of MPCA and Migration Inhibition

X. Characterization of the Lymphokine Inducing MPCA

XI. Fibronectin: Receptor for the Fibrin Network

XII. Blood Coagulation and Chemotaxis

XIII. Conclusion

References

A Chemically Defined Monokine: Macrophage-Derived Platelet-Activating Factor (PAF-Acether)

I. Introduction

II. Structure, Assay, and Characterization of PAF-Acether

III. Sources of PAF-Acether Other Than Macrophages

IV. Release of PAF-Acether from Peritoneal Macrophages

V. Release of PAF-Acether from Alveolar Macrophages and Monocytes

VI. PAF-Acether Metabolism

VII. Effects of PAF-Acether on Cells Involved in Inflammation

VIII. Pathobiological Effects of PAF-Acether

IX. Concluding Remarks

References

Genetic Control of the Response to Interferon in Man and Mouse

I. Introduction

II. The Interferon Receptor Locus (IFRC)

III. Other Loci Affecting the Response to Interferon

References

A Comparison of Immune Modulating Effects of Interferon and Interferon Inducers

I. Introduction

II. Effect on Antibody Production

III. Effects on Cellular Aspects of Immunity

IV. Effect on Hematopoietic Colony-Forming Cells

V. Effect on Macrophages

VI. Effects on Natural Killer Cell (NK Cell) Activity

VII. Effect on Antibody-Dependent Cell-Mediated Cytotoxic Activity (ADCC)

VIII. Conclusion

References

Ciliary Dyskinesia Factors Produced by Leukocytes

I. Introduction

II. Evidence That Leukocytes Generate Ciliary Dyskinesia Factors

III. Biochemical Properties and Functions of Ciliary Dyskinesia Factors

IV. The Monocyte-Macrophage as a Cellular Model for Studying Ciliary Dyskinesia Factor Metabolism

V. Concluding Remarks

References

Ceruloplasmin: An Acute Phase Reactant and Antioxidant

I. Introduction

II. Oxygen-Derived Free Radicals—Mediators of Inflammation

III. Ceruloplasmin—Some Chemical Properties and Biological Activities

IV. Antioxidant Activity of Ceruloplasmin

V. Ceruloplasmin—A Scavenger of Superoxide Anion Radicals

VI. Ceruloplasmin—An Acute-Phase Reactant

VII. Antiinflammatory Effects of Ceruloplasmin

References

Properties and Action Mechanism of Clastogenic Factors

I. Introduction

II. Preparation and Testing of Clastogenic Factors

III. Clastogenic Factors after X- and y-Irradiation

IV. Clastogenic Factors in Patients with Collagen Diseases

V. Clastogenic Factors in Other Diseases with Perturbations of the Immune System

VI. Clastogenic Factor in New Zealand Black Mice

VII. Clastogenic Factors in the Congenital Breakage Syndromes

VIII. Common Features and Properties of Clastogenic Factors

IX. Possible Action Mechanism of Clastogenic Factors

X. Significance of Clastogenic Factors

References

The Biological Effects and Mechanism of Action of the Plasma Tripeptide Glycyl-L-histidyl-L-lysine

I. Discovery of Glycyl-L-histidyl-L-lysine (GHL)

II. Biological Effects of GHL

III. Mechanism of Action of GHL

IV. Growth-Inhibitory Analogs of the GHL-Cu Complex



Index